Literature DB >> 28303425

Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project.

Amel Karaa1, Shamima Rahman2, Anne Lombès3, Patrick Yu-Wai-Man4,5,6, Muniza K Sheikh7, Sherita Alai-Hansen7, Bruce H Cohen8, David Dimmock9, Lisa Emrick10, Marni J Falk11,12, Shana McCormack11,12, David Mirsky13, Tony Moore14,15,16, Sumit Parikh17, John Shoffner18, Tanja Taivassalo19, Mark Tarnopolsky20, Ingrid Tein21, Joanne C Odenkirchen22, Amy Goldstein23.   

Abstract

OBJECTIVES: The common data elements (CDE) project was developed by the National Institute of Neurological Disorders and Stroke (NINDS) to provide clinical researchers with tools to improve data quality and allow for harmonization of data collected in different research studies. CDEs have been created for several neurological diseases; the aim of this project was to develop CDEs specifically curated for mitochondrial disease (Mito) to enhance clinical research.
METHODS: Nine working groups (WGs), composed of international mitochondrial disease experts, provided recommendations for Mito clinical research. They initially reviewed existing NINDS CDEs and instruments, and developed new data elements or instruments when needed. Recommendations were organized, internally reviewed by the Mito WGs, and posted online for external public comment for a period of eight weeks. The final version was again reviewed by all WGs and the NINDS CDE team prior to posting for public use.
RESULTS: The NINDS Mito CDEs and supporting documents are publicly available on the NINDS CDE website ( https://commondataelements.ninds.nih.gov/ ), organized into domain categories such as Participant/Subject Characteristics, Assessments, and Examinations.
CONCLUSION: We developed a comprehensive set of CDE recommendations, data definitions, case report forms (CRFs), and guidelines for use in Mito clinical research. The widespread use of CDEs is intended to enhance Mito clinical research endeavors, including natural history studies, clinical trial design, and data sharing. Ongoing international collaboration will facilitate regular review, updates and online publication of Mito CDEs, and support improved consistency of data collection and reporting.

Entities:  

Mesh:

Year:  2017        PMID: 28303425     DOI: 10.1007/s10545-017-0035-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

Review 1.  Mitochondrial respiratory-chain diseases.

Authors:  Salvatore DiMauro; Eric A Schon
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

2.  National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods.

Authors:  Stacie T Grinnon; Kristy Miller; John R Marler; Yun Lu; Alexandra Stout; Joanne Odenkirchen; Selma Kunitz
Journal:  Clin Trials       Date:  2012-02-27       Impact factor: 2.486

Review 3.  Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Authors:  Kathryn M Camp; Danuta Krotoski; Melissa A Parisi; Katrina A Gwinn; Bruce H Cohen; Christine S Cox; Gregory M Enns; Marni J Falk; Amy C Goldstein; Rashmi Gopal-Srivastava; Gráinne S Gorman; Stephen P Hersh; Michio Hirano; Freddie Ann Hoffman; Amel Karaa; Erin L MacLeod; Robert McFarland; Charles Mohan; Andrew E Mulberg; Joanne C Odenkirchen; Sumit Parikh; Patricia J Rutherford; Shawne K Suggs-Anderson; W H Wilson Tang; Jerry Vockley; Lynne A Wolfe; Steven Yannicelli; Philip E Yeske; Paul M Coates
Journal:  Mol Genet Metab       Date:  2016-09-20       Impact factor: 4.797

4.  mtDNA Variation and Analysis Using Mitomap and Mitomaster.

Authors:  Marie T Lott; Jeremy N Leipzig; Olga Derbeneva; H Michael Xie; Dimitra Chalkia; Mahdi Sarmady; Vincent Procaccio; Douglas C Wallace
Journal:  Curr Protoc Bioinformatics       Date:  2013-12

5.  Using ClinVar as a Resource to Support Variant Interpretation.

Authors:  Steven M Harrison; Erin R Riggs; Donna R Maglott; Jennifer M Lee; Danielle R Azzariti; Annie Niehaus; Erin M Ramos; Christa L Martin; Melissa J Landrum; Heidi L Rehm
Journal:  Curr Protoc Hum Genet       Date:  2016-04-01

6.  Fibroblast growth factor 21: a novel biomarker for human muscle-manifesting mitochondrial disorders.

Authors:  Anu Suomalainen
Journal:  Expert Opin Med Diagn       Date:  2013-06-20

Review 7.  Mitochondrial diseases.

Authors:  Gráinne S Gorman; Patrick F Chinnery; Salvatore DiMauro; Michio Hirano; Yasutoshi Koga; Robert McFarland; Anu Suomalainen; David R Thorburn; Massimo Zeviani; Douglass M Turnbull
Journal:  Nat Rev Dis Primers       Date:  2016-10-20       Impact factor: 52.329

8.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

9.  Guidelines for investigating causality of sequence variants in human disease.

Authors:  D G MacArthur; T A Manolio; D P Dimmock; H L Rehm; J Shendure; G R Abecasis; D R Adams; R B Altman; S E Antonarakis; E A Ashley; J C Barrett; L G Biesecker; D F Conrad; G M Cooper; N J Cox; M J Daly; M B Gerstein; D B Goldstein; J N Hirschhorn; S M Leal; L A Pennacchio; J A Stamatoyannopoulos; S R Sunyaev; D Valle; B F Voight; W Winckler; C Gunter
Journal:  Nature       Date:  2014-04-24       Impact factor: 49.962

10.  Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.

Authors:  Gráinne S Gorman; Andrew M Schaefer; Yi Ng; Nicholas Gomez; Emma L Blakely; Charlotte L Alston; Catherine Feeney; Rita Horvath; Patrick Yu-Wai-Man; Patrick F Chinnery; Robert W Taylor; Douglass M Turnbull; Robert McFarland
Journal:  Ann Neurol       Date:  2015-03-28       Impact factor: 10.422

View more
  7 in total

Review 1.  Identification of outcomes to inform the development of a core outcome set for surgical innovation: a targeted review of case studies of novel surgical devices.

Authors:  Nicholas Wilson; Rhiannon C Macefield; Christin Hoffmann; Matthew J Edmondson; Rachael L Miller; Emily N Kirkham; Natalie S Blencowe; Angus G K McNair; Barry G Main; Jane M Blazeby; Kerry N L Avery; Shelley Potter
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

Review 2.  Standardizing, harmonizing, and protecting data collection to broaden the impact of COVID-19 research: the rapid acceleration of diagnostics-underserved populations (RADx-UP) initiative.

Authors:  Gabriel A Carrillo; Michael Cohen-Wolkowiez; Emily M D'Agostino; Keith Marsolo; Lisa M Wruck; Laura Johnson; James Topping; Al Richmond; Giselle Corbie; Warren A Kibbe
Journal:  J Am Med Inform Assoc       Date:  2022-08-16       Impact factor: 7.942

3.  International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy.

Authors:  Michelangelo Mancuso; Robert McFarland; Thomas Klopstock; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2017-09-08       Impact factor: 4.296

Review 4.  The pursuit of precision mitochondrial medicine: Harnessing preclinical cellular and animal models to optimize mitochondrial disease therapeutic discovery.

Authors:  Marni J Falk
Journal:  J Inherit Metab Dis       Date:  2020-11-02       Impact factor: 4.982

5.  Diagnostic odyssey of patients with mitochondrial disease: Results of a survey.

Authors:  Johnston Grier; Michio Hirano; Amel Karaa; Emma Shepard; John L P Thompson
Journal:  Neurol Genet       Date:  2018-03-26

Review 6.  Moving towards clinical trials for mitochondrial diseases.

Authors:  Robert D S Pitceathly; Nandaki Keshavan; Joyeeta Rahman; Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2020-09-02       Impact factor: 4.982

Review 7.  Outcome selection, measurement and reporting for new surgical procedures and devices: a systematic review of IDEAL/IDEAL-D studies to inform development of a core outcome set.

Authors:  R C Macefield; N Wilson; C Hoffmann; J M Blazeby; A G K McNair; K N L Avery; S Potter
Journal:  BJS Open       Date:  2020-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.